Episode 96 - Jill Howe - CFO Lineage Cell Therapeutics episode artwork

EPISODE · Dec 3, 2025 · 25 MIN

Episode 96 - Jill Howe - CFO Lineage Cell Therapeutics

from The BioHub: The Top Voices in Biotech · host Max Brennan - Biotech HeadHunter

Welcome to another Episode of The BiohubToday, I’m joined by Jill Howe, Chief Financial Officer at Lineage Cell Therapeutics, a company developing groundbreaking allogeneic cell therapies for conditions like dry AMD, spinal cord injury, and hearing loss.Jill’s career spans more than 20 years across some of biotech’s most successful companies, helping take both Receptos and Gossamer Bio public before stepping into her current role at Lineage.We talk about what inspired her to join the company, how shehelps shape and protect Lineage’s culture, what excites her most about their pipeline, and her perspective on leadership and women in biotech.Let’s get into it.

Episode metadata supplied by the publisher feed · Published Dec 3, 2025

Embed this episode

NOW PLAYING

Episode 96 - Jill Howe - CFO Lineage Cell Therapeutics

0:00 25:33

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The BioHub: The Top Voices in Biotech?

This episode is 25 minutes long.

When was this The BioHub: The Top Voices in Biotech episode published?

This episode was published on December 3, 2025.

Can I download this The BioHub: The Top Voices in Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!